Category: Regulatory
What is Drug Labeling?
What is Drug Labeling? Drug labeling is the written, printed or graphic text that is placed with a pharmaceutical product either on the container, carton or package insert of the product. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and Cosmetic Act (FD&C Act) and FDA directions predetermine it.
What Is EU CTR Submission?
What Is EU CTR Submission? EU CTR submission means sending in clinical trial applications under the rules set by the European Union Clinical Trials Regulation (EU CTR 536/2014). This regulation covers how clinical trials for medicines get approved, run, and overseen in EU countries.
What is Permitted Daily Exposure (PDE) Calculation
What is Permitted Daily Exposure (PDE) Calculation At Masuu Global, patient safety is the central focus of pharmaceutical manufacturing and quality control. As companies increasingly use shared facilities to produce multiple products, the risk of cross-contamination becomes a major concern.
How to read a CEP – European Directorate for the Quality of Medicines(EDQM)
How to read a CEP – European Directorate for the Quality of Medicines(EDQM) Overview: Aim and scope of EDQM policy document PA/PH/CEP(15)31 “How to read a CEP” How to interpret the information laid down on CEPs
Regulatory Submissions Management: Driving Compliance and Speed in Global Markets
Regulatory Submissions Management: Driving Compliance and Speed in Global Markets These days, rules around the world keep getting stricter. If you’re trying to launch a new drug, medical device, or even a cosmetic, you can’t afford to mess up your regulatory submissions management process. Getting these submissions right quickly and by the book makes all… Continue reading Regulatory Submissions Management: Driving Compliance and Speed in Global Markets
EDQM GUIDELINE ON REQUIREMENTS FOR REVISION/RENEWAL OF CERTIFICATES OF SUITABILITY TO THE EUROPEAN PHARMACOPOEIA MONOGRAPHS
EDQM GUIDELINE ON REQUIREMENTS FOR REVISION/RENEWAL OF CERTIFICATES OF SUITABILITY TO THE EUROPEAN PHARMACOPOEIA MONOGRAPHS EDQM Guideline Revision: The European Directorate for the Quality of Medicines & HealthCare (EDQM) has revised the “Guideline on requirements for revision and renewal of certificates of suitability to the European Pharmacopoeia monographs” (PA/PH/CEP (04) 02) to align it with… Continue reading EDQM GUIDELINE ON REQUIREMENTS FOR REVISION/RENEWAL OF CERTIFICATES OF SUITABILITY TO THE EUROPEAN PHARMACOPOEIA MONOGRAPHS
What is a Common Technical Document (CTD)?
What is a Common Technical Document (CTD)? Pharmaceutical companies seeking global market approval must navigate complex regulatory requirements. To simplify submissions and harmonize standards, the International Council for Harmonisation (ICH) introduced the Common Technical Document (CTD). This format has become the backbone of regulatory filings worldwide, ensuring consistency, efficiency, and transparency in drug approval processes.
What is an Investigator’s Brochure (IB)?
What is an Investigator’s Brochure (IB)? Clinical trials are the foundation of pharmaceutical innovation, and their success depends on clear communication between sponsors and investigators. The Investigator’s Brochure (IB) is a critical document that provides comprehensive information about an investigational product, ensuring that clinical trial teams understand its properties, risks, and potential benefits. It serves… Continue reading What is an Investigator’s Brochure (IB)?
What is Document Management System (DMS)?
What is Document Management System (DMS)? In the pharmaceutical industry, documentation is the backbone of compliance, quality assurance, and regulatory approval. Every stage of drug development—from research to manufacturing—requires meticulous records.
What is a Regulatory Gap Analysis?
What is a Regulatory Gap Analysis? In the pharmaceutical industry, compliance with evolving global regulations is critical to ensure patient safety, product quality, and uninterrupted market access. A Regulatory Gap Analysis is a systematic process used by pharma companies to identify discrepancies between current practices and regulatory requirements.
